Showing results (291-300 of 314) with videos related to

Sort By:
Pageof 32
Plos One|October 2, 2008
Promoter DNA hypermethylation and gene repression in undifferentiated Arabidopsis cellsMaría Berdasco, Rubén Alcázar, María Victoria García-Ortiz, et al.
Frontiers in Genome Editing|November 19, 2025
Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113)María Ortiz-Bueno, Iris Ramos-Hernández, Luis Algeciras-Jiménez, et al.
Frontiers in Cellular Neuroscience|January 25, 2024
Potential contributions of the intrinsic retinal oscillations recording using non-invasive electroretinogram to bioelectronicsCynthia Alejandra Rodríguez-Arzate, Ramsés Noguez-Imm, Pamela Reyes-Ortega, et al.
Journal of Neuroimmunology|April 22, 2026
Peripheral lymphocyte subsets in spinocerebellar Ataxia type 2: Insights into disease mechanisms and potential immunomodulationYaimeé Vázquez-Mojena, Roberto Rodríguez-Labrada, Lisis Martínez Martí, et al.
Cerebellum (London, England)|October 20, 2023
COVID-19 Impacts the Mental Health and Speech Function in Spinocerebellar Ataxia Type 2: Evidences from a Follow-Up StudyLuis Velázquez-Pérez, Roberto Rodríguez-Labrada, Yasmany Gonzalez-Garcés, et al.
Schizophrenia Bulletin|March 15, 2013
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophreniaBorja García-Bueno, Miquel Bioque, Karina S Mac-Dowell, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2022
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal studyAlbert Martínez-Pinteño, Gisela Mezquida, Miquel Bioque, et al.
Cerebellum (London, England)|June 8, 2014
Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the diseaseLuis Velázquez-Pérez, Roberto Rodríguez-Labrada, Edilia M Cruz-Rivas, et al.
Neurochemical Research|May 13, 2011
Oral zinc sulphate supplementation for six months in SCA2 patients: a randomized, double-blind, placebo-controlled trialLuis Velázquez-Pérez, Jorge Rodríguez-Chanfrau, Julio Cesar García-Rodríguez, et al.
Cerebellum (London, England)|March 26, 2021
Impacts of the COVID-19 Pandemic on the Mental Health and Motor Deficits in Cuban Patients with Cerebellar AtaxiasYasmany González-Garcés, Yennis Domínguez-Barrios, Arianna Zayas-Hernández, et al.
Pageof 32